Dr. Wesolowski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1145 Olentangy River Rd
Ste 4000
Columbus, OH 43212Phone+1 614-293-0066Fax+1 614-293-7264- Is this information wrong?
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2007 - 2010- Cleveland Clinic FoundationResidency, Internal Medicine, 2004 - 2007
State University of New York Downstate Medical Center College of MedicineClass of 2004
Certifications & Licensure
OH State Medical License 2004 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- MINT I Multi- Institutional Neo-adjuvant Therapy MammaPrint Project I Start of enrollment: 2011 Oct 01
- Safety Study of PLX3397 and Paclitaxel in Patients With Advanced Solid Tumors Start of enrollment: 2012 May 01
- AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Subjects With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy Start of enrollment: 2016 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose ...E Claire Dees, Samuel Suzuki, Sarah C Mutka, Brian F Sullivan, Igor Gorbatchevsky, Rachel M Layman, Hyo S Han, Hope S Rugo, Erica M Stringer-Reasor, Jennifer M Specht,...> ;The Lancet. Oncology. 2024 Apr 1
- Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase.Savardekar, H., Allen, C., Jeon, H., Li, J., Quiroga, D., Schwarz, E., Wu, R., Zelinskas, S., Lapurga, G., Abreo, A., Stiff, A., Shaffer, J., Blaser, B., Old, M., Weso...> ;Molecular Cancer Research. 2024 Mar 1
- PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.Rodriguez, C., Kang, H., Babbar, N., Sun, W., Ferrarotto, R., Swiecicki, P., Zandberg, D., Baiocchi, R., Wesolowski, R., McKean, M., Monga, V., Nath, R., Palmisiano, N...> ;Oral Oncology. 2024 Feb 1
- Join now to see all
Journal Articles
- Modeling Combination Therapy for Breast Cancer with BET and Immune Checkpoint InhibitorsRobert Wesolowski, Andrew Stiff, Proceedings of the National Academy of Sciences
Press Mentions
Sanofi’s, AstraZeneca’s and Radius’ Oral SERDs Could Establish Clinical Worth in ER+ Breast Cancer by Showing Similar Efficacy to Faslodex, Experts SayApril 6th, 2021
A Solitary Brain Metastasis as the Only Site of Recurrence of HR Positive, HER2 Negative Breast Cancer: A Case Report and Review of the LiteratureJanuary 7th, 2021- FDA Approves at-Home, Post-Chemo Treatment for Breast CancerJuly 6th, 2020
- Join now to see all
Hospital Affiliations
Ohio State University Wexner Medical CenterColumbus, Ohio
The OSUCCC - JamesColumbus, Ohio
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
